SMMT - Summit Therapeutics Inc
IEX Last Trade
13
0.140 1.077%
Share volume: 2,106,166
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.86
0.14
1.09%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-11 | 2022-08-11 | 2022-11-09 | 2023-03-09 | 2023-05-11 | 2023-08-09 | |
| Assets | |||||||
| Total Assets | 116.472 M | 95.718 M | 155.327 M | 664.168 M | 254.897 M | 237.372 M | |
| Current Assets | 99.435 M | 79.398 M | 137.119 M | 656.712 M | 248.027 M | 227.501 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 21.115 M | 21.825 M | 15.008 M | 7.756 M | 6.095 M | 12.487 M | |
| Short Term Investments | 21.115 M | 21.825 M | 15.008 M | 7.756 M | 6.095 M | 12.487 M | |
| Total Receivables | 870.000 K | 238.000 K | 140.000 K | 349.000 K | 0.000 | 0.000 | |
| Current Cash | 77.450 M | 57.335 M | 121.971 M | 348.607 M | 241.932 M | 215.014 M | |
| Total Non-current Assets | 17.037 M | 16.320 M | 18.208 M | 7.456 M | 6.870 M | 9.871 M | |
| Property Plant Equipment | 965.000 K | 1.095 M | 930.000 K | 906.000 K | 412.000 K | 225.000 K | |
| Other Assets | 4.253 M | 4.519 M | 7.671 M | 4.752 M | 4.619 M | 7.763 M | |
| Intangible Assets | 9.866 M | 8.900 M | 7.952 M | 0.000 | 0.000 | 0.000 | |
| Goodwill | 1.953 M | 1.806 M | 1.655 M | 1.798 M | 1.839 M | 1.883 M | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 116.472 M | 95.718 M | 155.327 M | 664.168 M | 254.897 M | 237.372 M | |
| Total liabilities | 52.065 M | 44.401 M | 22.079 M | 537.514 M | 121.415 M | 117.773 M | |
| Total current liabilities | 22.724 M | 15.173 M | 16.682 M | 38.782 M | 17.443 M | 11.931 M | |
| Accounts Payable | 6.959 M | 3.574 M | 1.431 M | 355.000 K | 710.000 K | 987.000 K | |
| Other liabilities | 2.751 M | 2.594 M | 2.424 M | 1.429 M | 1.481 M | 1.511 M | |
| Current long term debt | 907.000 K | 684.000 K | 1.392 M | 21.460 M | 1.693 M | 2.928 M | |
| Long term debt | 26.590 M | 26.634 M | 2.973 M | 497.303 M | 102.491 M | 104.331 M | |
| Other liabilities | 2.751 M | 2.594 M | 2.424 M | 1.429 M | 1.481 M | 1.511 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 64.407 M | 51.317 M | 133.248 M | 126.654 M | 133.482 M | 119.599 M | |
| Common stock | 98.070 M | 99.654 M | 148.583 M | 427.037 M | 378.164 M | 697.685 M | |
| Retained earnings | -320.945 M | -337.716 M | -359.101 M | -378.330 M | -920.706 M | -935.423 M |